BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
17,520
-1,010 (-5.45%)
At close: Aug 1, 2025, 3:30 PM KST
BIO-FD&C Revenue
BIO-FD&C had revenue of 4.32B KRW in the quarter ending March 31, 2025, with 13.78% growth. This brings the company's revenue in the last twelve months to 16.59B, up 3.30% year-over-year. In the year 2024, BIO-FD&C had annual revenue of 16.07B with 3.04% growth.
Revenue (ttm)
16.59B
Revenue Growth
+3.30%
P/S Ratio
10.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
165.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.07B | 474.34M | 3.04% |
Dec 31, 2023 | 15.59B | -263.23M | -1.66% |
Dec 31, 2022 | 15.86B | 3.88B | 32.43% |
Dec 31, 2021 | 11.97B | 3.33B | 38.57% |
Dec 31, 2020 | 8.64B | 163.27M | 1.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
KB Financial Group | 15.69T |
Doosan Enerbility | 15.88T |